Vivos Therapeutics, Inc. Q3 FY25 Results

We are very pleased to announce that our third quarter sequential revenue was up 78%, while same period year-over-year revenue increased 76%. This outstanding quarterly revenue increase represents exactly what we anticipated when we announced and executed our strategic pivot away from our historical reliance on a dental industry distribution channel and toward a direct affiliation with, or acquisition of, medical sleep practices and testing centers. This pivot was showcased by our June 2025 acquisition of The Sleep Center of Nevada (SCN). Importantly, these results highlight the impact of our first full quarter of operations since our SCN acquisition. Even at this early stage, we are seeing the benefits of our strategic pivot in both revenue and gross profit, and these results provide us with confidence in where our new strategic affiliation and acquisition model will take us. We believe significant local market growth potential remains in the Las Vegas area as we continue to integrate and optimize SCN’s operations and expand our capacity to meet what we have found to be overwhelming and growing patient demand. We are currently booking SCN patients for sleep testing out into the latter part of February 2026 as we work to rapidly add additional facilities, staff and providers. In addition, as previously announced, we are actively looking to extend our model into additional major markets beyond Las Vegas, whether through contractual alliances with, or acquisitions of, sleep medical practices.

The launch of our new model at SCN required key investments in people and infrastructure in advance of full-capacity revenue generating operations. This resulted in some higher levels of expenses during the quarter. We expect this to continue near term as we seek to optimize SCN’s operations by driving revenue further, adding staff, and eventually getting more providers credentialed with insurance payors. During 2026, we expect to continue to add new sleep optimization teams, which we believe will eventually result in a reduction in cash burn and create the potential for profitable operations. Concurrently, we are seeking to expand revenue opportunities through additional acquisitions or contractual alliances with medical sleep providers and testing centers in key target markets.”